英唐智控(300131.SZ):預計2024年有望完成MEMS微振鏡自動裝配產線的組裝及調試並開啟批量銷售
格隆匯12月26日丨有投資者於投資者互動平台向英唐智控(300131.SZ)提問,“請問公司的微振鏡目前已為哪些車企供貨?”,公司回覆稱,公司目前研發的MEMS微振鏡規格有φ1.0mm、φ4.0mm、φ8.0mm,其中φ4.0mm、φ8.0mm規格的已有樣品訂單。公司將竭盡全力加快推進MEMS微振鏡在終端激光雷達廠商和車廠的實際應用。根據項目當前的研發進度,預計2024年有望完成MEMS微振鏡自動裝配產線的組裝及調試並開啟批量銷售。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.